Europe Single-Cell Multi-Omics Market: Analysis and Forecast, 2023-2033

1.1 Global Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.2 Market Overview
1.2.1 Key Findings
1.2.2 Current Market Scenario
1.2.2.1 For Researchers
1.2.2.2 For Diagnostics
1.3 Industry Outlook
1.3.1 Regulatory Framework
1.3.2 Patent Analysis
1.3.2.1 Awaited Technological Developments
1.3.2.2 Patent Filing Trend (by Country)
1.3.2.3 Patent Filing Trend (by Year)
1.3.3 Key Trends
1.3.3.1 Advancements in Imaging Techniques for Single-Cell Sequencing
1.3.3.2 Use of Artificial Intelligence (AI) and Machine Learning (ML) in Single-Cell Multi-Omics
1.3.3.3 Increased Development of Advanced Solution Based on Single-Cell Technology
1.3.4 Opportunity Assessment
1.3.5 Product Benchmarking
1.3.6 Clinical Trials
1.4 COVID-19 Impact
1.4.1 Pre-COVID-19
1.4.2 During COVID-19
1.4.3 Post COVID-19
1.5 Business Dynamics
1.5.1 Impact Analysis
1.5.2 Business Drivers
1.5.2.1 Rising Number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (Sc-RNA)
1.5.2.2 Use of Single-Cell Multi-Omics Approach for Screening and Diagnostics of Diseases Leading to Shift Toward Personalized Medicine
1.5.2.3 Increasing Use of Single-Cell Multi-Omics for Drug Development
1.5.2.4 Collaborations among Technology Providers and Life Sciences Companies for Accelerating the Research in Single-Cell Multi-Omics
1.5.3 Business Restraints
1.5.3.1 High Cost of Single-Cell Analysis and Sequencing
1.5.3.2 Limited Availability of Large Online Data Storage and Analysis Platforms
1.5.4 Business Opportunities
1.5.4.1 Expansion into New Research Applications, Such as Single-Cell Metabolomics
1.5.4.2 Increasing Adoption of Genomic-Based Medicine in Emerging Nations

2.1 Europe
2.1.1 Key Findings and Opportunity Assessment
2.1.2 Market Dynamics
2.1.2.1 Impact Analysis
2.1.3 Market Sizing and Forecast
2.1.3.1 Europe Single-Cell Multi-Omics Market (by Country)
2.1.3.1.1 Germany
2.1.3.1.2 Italy
2.1.3.1.3 U.K.
2.1.3.1.4 Spain
2.1.3.1.5 France
2.1.3.1.6 Rest-of-Europe

3.1 Competitive Benchmarking
3.1.1 Key Strategies and Developments
3.1.1.1 Funding Activities
3.1.1.2 New Offerings
3.1.1.3 Mergers and Acquisitions
3.1.1.4 Partnership, Collaboration, and Business Expansion
3.1.2 Market Share Analysis
3.1.3 Growth Share Analysis
3.1.3.1 By Application
3.1.3.2 By Omics Type
3.1.3.3 By Product Type
3.1.4 Visual Graphics of the Companies
3.1.5 Multi-Omics Ecosystem Active Players
3.2 Company Profiles
3.2.1 Menarini Group
3.2.1.1 Company Overview
3.2.1.2 Role of Menarini Group in the Single-Cell Multi-Omics Market
3.2.1.3 Analyst Perspective
3.2.2 QIAGEN NV
3.2.2.1 Company Overview
3.2.2.2 Role of QIAGEN NV in the Single-Cell Multi-Omics Market
3.2.2.3 Financials
3.2.2.4 Analyst Perspective
3.2.3 Rarecells Diagnostics
3.2.3.1 Company Overview
3.2.3.2 Role of Rarecells Diagnostics in the Single-Cell Multi-Omics Market
3.2.3.3 Analyst Perspective
3.2.4 Scipio Bioscience
3.2.4.1 Company Overview
3.2.4.2 Role of Scipio Bioscience in the Single-Cell Multi-Omics Market
3.2.4.3 Analyst Perspective
3.2.5 Singleron Biotechnologies
3.2.5.1 Company Overview
3.2.5.2 Role of Singleron Biotechnologies in the Single-Cell Multi-Omics Market
3.2.5.3 Recent Developments
3.2.5.4 Analyst Perspective

Figure 1: An Overview of Single-Cell Multi-Omics Sequencing Technologies
Figure 2: Single-Cell Multi-Omics Market, Impact Analysis
Figure 3: Single-Cell Multi-Omics Market (by Region), $Billion, 2022 and 2033
Figure 4: Single-Cell Multi-Omics Market: Research Methodology
Figure 5: Primary Research Methodology
Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
Figure 7: Top-Down Approach (Segment-Wise Analysis)
Figure 8: Single-Cell Multi-Omics Market, Patent Analysis (by Country), January 2018- March 2023
Figure 9: Single-Cell Multi-Omics Market, Patent Analysis (by Year), January 2018-December2022
Figure 10: Single-Cell Multi-Omics Market, Key Trends, Market Shift, 2022-2033
Figure 11: Single-Cell Multi-Omics Market, Impact Analysis
Figure 12: Global Data for Rare Diseases, 2020
Figure 13: Companies Using Multi-Omics Approach in Research and Development of Drugs and Vaccines
Figure 14: Advantages of Multi-Omics in Drug Discovery and Development
Figure 15: Cost of Single Cell Sequencing (by Company)
Figure 16: Some of the Advancements in Single-Cell Metabolomics
Figure 17: Single-Cell Multi-Omics Market Share (by Region)
Figure 18: Europe Single-Cell Multi-Omics Market, Incremental Opportunity (by Country), $Million, 2023-2033
Figure 19: Europe Single-Cell Multi-Omics Market, $Billion, 2022-2033
Figure 20: Europe Single-Cell Multi-Omics Market (by Country), % Share, 2022 and 2033
Figure 21: Germany Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 22: Italy Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 23: U.K. Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 24: Spain Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 25: France Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 26: Rest-of-Europe Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 27: Single-Cell Multi-Omics Market, Number of Key Developments and Strategies, January 2018-March 2023
Figure 28: Funding Activities, January 2018-March 2023
Figure 29: New Offerings, January 2018-March 2023
Figure 30: Mergers and Acquisitions, January 2018-March 2023
Figure 31: Partnership, Collaboration, and Business expansion, January 2018-March 2023
Figure 32: Single-Cell Multi-Omics Market, Company Revenue Share Analysis, $Billion, 2022
Figure 33: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Application), 2023-2033
Figure 34: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Omics Type), 2023-2033
Figure 35: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Product Type), 2023-2033
Figure 36: Single Cell Multi Omics Market, Visual Graphics of the Companies
Figure 37: Menarini Silicon Biosystems: Product Portfolio
Figure 38: QIAGEN NV: Product Portfolio
Figure 39: QIAGEN NV: Overall Financials, $Million, 2020-2022
Figure 40: QIAGEN NV: Net Revenue (by Segment), $Million, 2020-2022
Figure 41: QIAGEN NV: Net Revenue (by Region), $Million, 2020-2022
Figure 42: QIAGEN NV: R&D Expenditure, $Million, 2020-2020
Figure 43: Rarecells Diagnostics: Product Portfolio
Figure 44: Scipio Bioscience: Product Portfolio
Figure 45: Singleron Biotechnologies: Product Portfolio

Table 1: Single-Cell Multi-Omics Market, Key Developments Analysis, January 2018-March 2023
Table 2: Key Questions Answered in the Report
Table 3: Single-Cell Multi-Omics Market: Global Regulatory Organization
Table 4: Single-Cell Multi-Omics Market, Product Benchmarking
Table 5: Single-Cell Multi-Omics Market, Ongoing Clinical Trials
Table 6: Single-Cell Multi-Omics Platforms Used in the Diagnosis of Disease
Table 7: Recent Collaborations between Technology Providers and Life Sciences Companies
Table 8: Europe Single-Cell Multi-Omics Market Dynamics, Impact Analysis
Table 9: Multi-Omics Ecosystem Active Players